Patents Assigned to Novira Therapeutics, INC.
  • Combinations and methods comprising a capsid assembly inhibitor
    Patent number: 11129834
    Abstract: The present disclosure is directed to capsid assembly inhibitor compositions and methods for use in the treatment of hepatitis B virus infection.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: September 28, 2021
    Assignees: Novira Therapeutics, Inc., Janssen Sciences Ireland Unlimited Company
    Inventors: George Hartman, Osvaldo Flores, Klaus Klumpp, Man Iu Lam, Jan Martin Berke
  • Oxadiazepinone derivatives and methods of treating hepatitis B infections
    Patent number: 10987359
    Abstract: Provided herein are compounds of formula (IA) and (III) useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: April 27, 2021
    Assignee: Novira Therapeutics, Inc.
    Inventors: Scott Kuduk, George D. Hartman
  • Diazepinone derivatives and their use in the treatment of hepatitis B infections
    Patent number: 10975077
    Abstract: Provided herein are compounds of formula (I) and (V) useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: April 13, 2021
    Assignee: Novira Therapeutics, Inc.
    Inventors: Scott Kuduk, George D. Hartman
  • Hepatitis B antiviral agents
    Patent number: 9205079
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in man.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: December 8, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventor: George D. Hartman
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9181288
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: November 10, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Scott Kuduk
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9169212
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: October 27, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Scott Kuduk
  • Azepane derivatives and methods of treating hepatitis B infections
    Patent number: 9115113
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: August 25, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventor: George D Hartman
  • Hepatitis B antiviral agents
    Patent number: 9066932
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: June 30, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Osvaldo A. Flores
  • Hepatitis B antiviral agents
    Patent number: 9061008
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: June 23, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Osvaldo A. Flores
  • Hepatitis B antiviral agents
    Patent number: 8993771
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in man.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: March 31, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventor: George D. Hartman
  • Hepatitis B antiviral agents
    Patent number: 8629274
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: January 14, 2014
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Osvaldo A. Flores
  • HEPATITIS B ANTIVIRAL AGENTS
    Publication number: 20130251673
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Application
    Filed: December 21, 2012
    Publication date: September 26, 2013
    Applicant: Novira Therapeutics, INC.
    Inventors: George D. HARTMAN, Osvaldo A. FLORES